Advanced search
Publication Cover
Modern Rheumatology Volume 28, 2018 - Issue 1
Journal homepage
2,940
Views
6
CrossRef citations to date
0
Altmetric
Original Article

Long-term safety and effectiveness of adalimumab for the treatment of Japanese patients with rheumatoid arthritis: 3-year results from a postmarketing surveillance of 552 patients

Masayoshi HarigaiDivision of Epidemiology and Pharmacoepidemiology of Rheumatic Diseases, Institute of Rheumatology, Tokyo Women’s Medical University, Tokyo, Japan; Correspondence[email protected]
,
Tsuyoshi TsuchiyaMedical, AbbVie GK, Tokyo, Japan
,
Katsuyoshi KawanaMedical, AbbVie GK, Tokyo, Japan
&
Sarina KurimotoMedical, AbbVie GK, Tokyo, Japan
Pages 30-38 | Received 04 Oct 2016, Accepted 03 Mar 2017, Published online: 07 Apr 2017

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

Order Reprints Request Permissions

For more information please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.